Royalty Pharma Leads Life Sci Trio Set To Raise $2.2B In IPOs
Three life sciences companies — Royalty Pharma, Vaxcyte and Generation Bio — set terms Monday for initial public offerings expected to bring in a combined $2.2 billion, with Royalty Pharma prepping...To view the full article, register now.
Already a subscriber? Click here to view full article